REGN vs UBER
Regeneron Pharmaceuticals Inc (REGN) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the REGN and UBER stock pages for the full models.
Not investment advice.